GleamWall
中文EN

MDCE Medical Care Technologies Inc.

Services-Business Services, NEC · OTC · SEC CIK 1404593 · Fiscal year ends 12/31

Financial factors as of 2012-09-30 (2012Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-64.4%
TTM EPS YoY100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-395.8%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets119.8%
Debt / equity—
Current ratio0.16x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.10x
Accruals ratio-354.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2012Q32012-09-302012Q22012-06-302012Q12012-03-312011Q4*2011-12-312011Q32011-09-302011Q22011-06-302011Q12011-03-312010Q4*2010-12-31
Income statement
Revenue————————
SG&A expense$372,569$320,612$93,691$148,808$223,073$437,136$67,017$130,021
Interest expense$136,938$137,644$92,481$164,015$135,748$175,035$12,369$341
Pretax income-$711,129-$1.34M-$378,217-$468,456-$504,397-$834,029-$127,666-$292,165
Net income-$709,811-$1.34M-$371,771-$463,993-$501,540-$832,141-$126,213-$292,165
EPS (basic)0.000.000.00—0.000.000.00—
EPS (diluted)0.000.000.00—0.000.000.00—
Weighted avg. shares (diluted)2.51B———229.92M———
Balance sheet
Cash & equivalents$742$379$784$3,380$26,698$24,195$6,791$391
Current assets$221,810$203,982$43,853$45,062$293,489$342,091—$6,891
PP&E, net$31,002$31,002$20,151$6,200$2,500$5,000—$10,000
Intangibles$897,148$897,148$457,695$457,695———$0
Total assets$1.15M$1.13M$552,955$513,921$302,966$353,985—$16,891
Current liabilities$1.38M$1.46M$571,761$521,455———$246,253
Total liabilities$1.38M$1.46M$703,766$652,409$447,285$486,067—$246,253
Shareholders' equity-$228,469-$331,068-$295,525-$138,488-$235,636-$226,231—-$229,362
Shares outstanding3.24B1.84B566.39M328.90M244.47M213.02M—161.01M
Cash flow statement
Operating cash flow-$87,696-$51,820-$58,139-$102,113-$94,056-$103,551-$72,200-$31,922
Investing cash flow$285,645——-$206,200———$0
Financing cash flow-$197,586$490,868$55,543$284,995$354,254$120,955$78,600$31,128
Depreciation & amortization———-$8,402$8,942$6,960$2,500$149,072
Stock-based compensation$41,000$444,478$40,026$57,065$207,146$473,816$50,159$79,622

Free plan shows the latest 8 periods; Pro shows all 10 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.